Elucidating the exact pharmacological mechanism of action (MOA) of Obviously occurring compounds is usually challenging. Despite the fact that Tarselli et al. (60) produced the 1st de novo synthetic pathway to conolidine and showcased this Obviously happening compound correctly suppresses responses to both of those chemically induced and inflammati